Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00929500 · ClinicalTrials.gov registry record · NA
Exercise Program in Women With Metabolic Syndrome
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT00929500 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 28 participants.
The verdict
NCT00929500, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether a supervised mixed aerobic and strength training (MAST) program is effective in improving overall physical fitness and blood flow in the brain and lowering risk factors of coronary artery disease (CAD) in women with metabolic syndrome.
Interventions
- BEHAVIORAL MAST program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2009-07 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00929500
The ClinicalTrials.gov registry entry for NCT00929500 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MAST program is the first listed.
NCT00929500 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00929500 about?
NCT00929500 is a clinical study titled "Exercise Program in Women With Metabolic Syndrome". The purpose of this study is to test whether a supervised mixed aerobic and strength training (MAST) program is effective in improving overall physical fitness and blood flow in the brain and lowering risk factors of coronary artery disease (CAD) in women with metabolic syndrome.
What is the current status of trial NCT00929500?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2009-07. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00929500?
The interventions under investigation include: MAST program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00929500?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.